Trials / Withdrawn
WithdrawnNCT00108602
Sleep Apnea: Mechanism and Cerebrovascular Consequences
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- US Department of Veterans Affairs · Federal
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine the effect of ventilatory stimulation on obstructive sleep apnea in selected patients with stroke. We will select a subset of patients with stroke in the prior 3 months who are most likely to have ventilatory instability as a cause of the upper airway obstruction as indicated by the absence of obesity, an abnormal hypocapnic apnea threshold and resolution of obstructive apnea during CO2 administration. Following baseline polysomnography, patients will be randomly assigned to acetazolamide (250 mg hs \[at bedtime\]) versus placebo for 7 days. Polysomnography will be repeated and then subjects will cross-over therapies for another 7 days followed by a final nocturnal polysomnography.
Detailed description
This study never enrolled patients. It was a component of a larger VA Merit grant and the other aims of the grant were completed but due to logistic issues and recruitment challenges this particular protocol was never made active.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | acetazolamide |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2005-04-18
- Last updated
- 2015-06-26
Source: ClinicalTrials.gov record NCT00108602. Inclusion in this directory is not an endorsement.